Debiopharm Innovation Fund
Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.
Business Model:
Revenue: $43.3M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Debiopharm Innovation Fund Information
Geographic Data
Address: Chemin Messidor 5-7
City: Lausanne
State: vaud
Zip: CH-1002
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge &a; networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2020 | Nucleai | Series A | 0 |
| 2/2021 | Carevive Systems | Series C | 0 |
| 3/2022 | VivoSense | Series A | 0 |
| 9/2020 | Oncomfort | Series A | 0 |
| 5/2017 | BC Platforms | Series B | 10M |
| 11/2013 | Biocartis | Series E | 0 |
| 5/2022 | Mika | Series A | 0 |
| 11/2014 | Coorpacademy | Series A | 4M |
| 3/2023 | Genialis | Series A | 0 |
| 2/2020 | Carevive Systems | Series C | 0 |
| 11/2020 | Voluntis | Post-IPO Equity | - |
| 11/2022 | YonaLink | Seed Round | 6M |
| 6/2013 | Diagnoplex | Venture Round | 1.4M |
| 12/2019 | BC Platforms | Series C | 15M |
| 4/2018 | Kaiku Health | Series A | 5.4M |
| 11/2021 | Mekonos | Series A | 0 |
| 6/2005 | Neovacs | Venture Round | - |
| 10/2012 | Searchbox | Series B | - |
| 3/2022 | Nucleai | Series B | 0 |
| 1/2022 | VeriSIM Life | Series A | 0 |
| 2/2018 | ABAC Therapeutics | Series A | 0 |
| 9/2013 | KeyLemon | Series A | 1.5M |
| 5/2022 | Mika | Series A | 0 |
| 3/2022 | VivoSense | Series A | 0 |
| 3/2022 | Nucleai | Series B | 0 |
| 1/2022 | VeriSIM Life | Series A | 0 |
| 11/2021 | Mekonos | Series A | 0 |
| 2/2021 | Carevive Systems | Series C | 0 |
| 11/2020 | Voluntis | Post-IPO Equity | - |
| 9/2020 | Oncomfort | Series A | 0 |
| 7/2020 | Nucleai | Series A | 0 |
| 2/2020 | Carevive Systems | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
